JP2002503673A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002503673A5 JP2002503673A5 JP2000531466A JP2000531466A JP2002503673A5 JP 2002503673 A5 JP2002503673 A5 JP 2002503673A5 JP 2000531466 A JP2000531466 A JP 2000531466A JP 2000531466 A JP2000531466 A JP 2000531466A JP 2002503673 A5 JP2002503673 A5 JP 2002503673A5
- Authority
- JP
- Japan
- Prior art keywords
- valyloxy
- isoleucyloxy
- propionyl
- formula
- embedded image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 aliphatic L-amino acids Chemical class 0.000 description 11
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800452-6 | 1998-02-13 | ||
| SE9800452A SE9800452D0 (sv) | 1998-02-13 | 1998-02-13 | Antivirals |
| SE9800469A SE9800469D0 (sv) | 1998-02-16 | 1998-02-16 | Pharmaceuticals |
| SE9801216A SE9801216D0 (sv) | 1998-04-03 | 1998-04-03 | Pharmaceuticals |
| ZA987267A ZA987267B (en) | 1997-08-15 | 1998-08-13 | Nucleosides |
| PCT/SE1998/001467 WO1999009031A1 (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| SE9801216-4 | 1998-10-07 | ||
| SE9800469-0 | 1998-10-07 | ||
| SE98/7267 | 1998-10-07 | ||
| SE9803438A SE9803438D0 (sv) | 1998-10-07 | 1998-10-07 | Antivirals |
| SE9801467 | 1998-10-07 | ||
| SE9803438-2 | 1998-10-07 | ||
| PCT/SE1999/000194 WO1999041275A1 (en) | 1998-02-13 | 1999-02-15 | Prodrugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002503673A JP2002503673A (ja) | 2002-02-05 |
| JP2002503673A5 true JP2002503673A5 (cg-RX-API-DMAC10.html) | 2006-04-06 |
Family
ID=56289887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000531466A Pending JP2002503673A (ja) | 1998-02-13 | 1999-02-15 | プロドラッグ群 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US6458772B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1054891A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002503673A (cg-RX-API-DMAC10.html) |
| AU (1) | AU754733B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2318978A1 (cg-RX-API-DMAC10.html) |
| EA (1) | EA002647B1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO1999041275A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458772B1 (en) * | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
| WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| PL359169A1 (en) * | 2000-05-26 | 2004-08-23 | Idenix (Cayman) Limited | Methods and compositions for treating flaviviruses and pestiviruses |
| US7527807B2 (en) * | 2000-06-21 | 2009-05-05 | Cubist Pharmaceuticals, Inc. | Compositions and methods for increasing the oral absorption of antimicrobials |
| AU2001271259A1 (en) * | 2000-06-28 | 2002-01-08 | Intertainer, Inc. | Intelligent media targeting system and method |
| WO2002044324A2 (en) | 2000-10-06 | 2002-06-06 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| IL142535A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
| WO2003024429A1 (en) * | 2001-09-21 | 2003-03-27 | Egalet A/S | Polymer release system |
| US20050019399A1 (en) * | 2001-09-21 | 2005-01-27 | Gina Fischer | Controlled release solid dispersions |
| KR20050035194A (ko) | 2002-06-28 | 2005-04-15 | 이데닉스 (케이만) 리미티드 | 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘 |
| US7608600B2 (en) * | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| CN101172993A (zh) | 2002-06-28 | 2008-05-07 | 埃迪尼克斯(开曼)有限公司 | 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷 |
| CN100582085C (zh) * | 2002-10-10 | 2010-01-20 | 耶达研究及发展有限公司 | 脂肪醇的碱性酯及它们作为抗炎药或免疫调节剂的用途 |
| US20040152769A1 (en) * | 2002-11-09 | 2004-08-05 | Ekwuribe Nnochiri Nkem | Modified carbamate-containing prodrugs and methods of synthesizing same |
| AU2003298658A1 (en) | 2002-11-15 | 2004-06-15 | Idenix (Cayman) Limited | 2'-branched nucleosides and flaviviridae mutation |
| US7598373B2 (en) | 2002-12-12 | 2009-10-06 | Idenix Pharmaceuticals, Inc. | Process for the production of 2-C-methyl-D-ribonolactone |
| GB0301938D0 (en) * | 2003-01-28 | 2003-02-26 | Biochemie Gmbh | Organic compounds |
| US8877241B2 (en) | 2003-03-26 | 2014-11-04 | Egalet Ltd. | Morphine controlled release system |
| EP1610797A1 (en) * | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antiviral combination of nevirapine and a further antiretroviral compound |
| ATE420188T1 (de) | 2004-02-02 | 2009-01-15 | Pioneer Hi Bred Int | Ap2-domäne-transkriptionsfaktor odp2 (ovule development protein 2) und verwendungsverfahren |
| NZ580951A (en) * | 2005-04-29 | 2011-06-30 | Cubist Pharm Inc | Therapeutic compositions |
| US7781576B2 (en) | 2005-12-23 | 2010-08-24 | Idenix Pharmaceuticals, Inc. | Process for preparing a synthetic intermediate for preparation of branched nucleosides |
| WO2007084548A2 (en) * | 2006-01-18 | 2007-07-26 | Fil-Am Tech., Inc. | Viral treatment |
| WO2008106092A1 (en) * | 2007-02-26 | 2008-09-04 | Yeda Research And Development Co. Ltd. | Enantiomers of amino-phenyl-acetic acid octadec- 9- (z) enyl ester, their salts and their uses |
| WO2008106091A1 (en) * | 2007-02-26 | 2008-09-04 | Yeda Research And Development Co. Ltd. | Use of long-chain alcohol derivatives for the treatment of alopecia areata |
| US8821928B2 (en) | 2007-06-04 | 2014-09-02 | Egalet Ltd. | Controlled release pharmaceutical compositions for prolonged effect |
| PT2514750E (pt) | 2007-06-18 | 2014-01-23 | Sunshine Lake Pharma Co Ltd | Tiazolil dihidropirimidinas substituídas com bromo-fenilo |
| NZ594207A (en) | 2009-02-06 | 2013-03-28 | Egalet Ltd | Immediate release composition resistant to abuse by intake of alcohol |
| AU2010265213B2 (en) | 2009-06-24 | 2012-08-23 | Egalet Ltd. | Controlled release formulations |
| CA2793596A1 (en) | 2009-12-30 | 2011-07-07 | Pioneer Hi-Bred International, Inc. | Methods and compositions for targeted polynucleotide modification |
| CA2793600C (en) | 2009-12-30 | 2020-01-14 | Pioneer Hi-Bred International, Inc. | Methods and compositions for the introduction and regulated expression of genes in plants |
| US8530444B2 (en) * | 2010-06-01 | 2013-09-10 | Aposense Ltd. | Pharmaceutical compounds |
| US9192680B2 (en) | 2010-06-01 | 2015-11-24 | Aposense Ltd. | Pharmaceutical compounds |
| KR20140007443A (ko) * | 2011-02-21 | 2014-01-17 | 메디비르 아베 | Flg의 합성 |
| CN108283000B (zh) | 2015-09-23 | 2021-04-13 | 凯瑞康宁生物工程(武汉)有限公司 | γ-羟基丁酸的前药及其组合物和用途 |
| KR102510784B1 (ko) | 2017-03-30 | 2023-03-15 | 엑스더블유파마 리미티드 | 이환형 헤테로아릴 유도체 및 이의 제조 및 용도 |
| CN114042070A (zh) | 2018-09-30 | 2022-02-15 | 凯瑞康宁生物工程(武汉)有限公司 | 作为神经元组胺受体-3拮抗剂的化合物及其用途 |
| WO2021127461A1 (en) | 2019-12-20 | 2021-06-24 | Xw Laboratories Limited | Methods of synthesizing 4-valyloxybutyric acid |
| AU2021292406B2 (en) | 2020-06-18 | 2024-03-14 | XWPharma Ltd. | Controlled release granulations of water-soluble active pharmaceutical ingredients |
| KR102982616B1 (ko) | 2020-06-18 | 2026-06-26 | 엑스더블유파마 리미티드 | 수용성 원료의약품의 약학적 과립화제 |
| WO2022020621A1 (en) | 2020-07-24 | 2022-01-27 | XWPharma Ltd. | Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative |
| AU2021357705B2 (en) | 2020-10-05 | 2024-09-26 | XWPharma Ltd. | Modified release compositions of a gamma-hydroxybutyric acid derivative |
| DK4308086T3 (da) | 2021-03-19 | 2025-11-17 | Xwpharma Ltd | Farmakokinetik af formuleringer med kombineret frigivelse af et gamma-hydroxysmørsyrederivat |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458772B1 (en) * | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
| IE34948B1 (en) | 1970-03-12 | 1975-10-01 | Leo Pharm Prod Ltd | New penicillin esters |
| US3705191A (en) | 1970-04-13 | 1972-12-05 | Monsanto Co | Substituted ethane diphosphonic acids and salts and esters thereof |
| US4168267A (en) | 1978-10-23 | 1979-09-18 | E. R. Squibb & Sons, Inc. | Phosphinylalkanoyl prolines |
| GB2043072B (en) | 1979-02-13 | 1983-11-23 | Symphar Sa | Diphosphonate compounds |
| US4486425A (en) | 1980-09-30 | 1984-12-04 | Sankyo Company Limited | 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates |
| US4337201A (en) | 1980-12-04 | 1982-06-29 | E. R. Squibb & Sons, Inc. | Phosphinylalkanoyl substituted prolines |
| US4760057A (en) | 1983-06-23 | 1988-07-26 | Merck & Co., Inc. | (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs |
| US4594199A (en) | 1983-09-19 | 1986-06-10 | E. R. Squibb & Sons, Inc. | Method for making phosphinic acid intermediates |
| GB8421112D0 (en) | 1984-08-20 | 1984-09-26 | Unilever Plc | Pyroglutamic acid esters |
| US4968788A (en) | 1986-04-04 | 1990-11-06 | Board Of Regents, The University Of Texas System | Biologically reversible phosphate and phosphonate protective gruops |
| SE8602981D0 (sv) | 1986-07-04 | 1986-07-04 | Astra Laekemedel Ab | Novel medicinal use |
| DE3623397A1 (de) | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| DD279407A1 (de) | 1986-07-24 | 1990-06-06 | Akad Wissenschaften Ddr | Verfahren zur herstellung eines mittels gegen aids |
| DK406686D0 (da) | 1986-08-26 | 1986-08-26 | Hans Bundgaard | Carboxylsyrederivater |
| GB8719367D0 (en) | 1987-08-15 | 1987-09-23 | Wellcome Found | Therapeutic compounds |
| EP0339075B1 (en) | 1987-10-28 | 1993-08-18 | Pro-Neuron, Inc. | Acylated uridine and cytidine and uses thereof |
| US5198539A (en) | 1988-08-19 | 1993-03-30 | Burroughs Wellcome Co. | 5'-esters of 2',3'-dideoxy-3'-fluoro-5-ethynyluridine |
| CA2002648C (en) | 1988-11-15 | 2000-02-29 | James R. Mccarthy | 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives |
| US5043339A (en) | 1988-12-19 | 1991-08-27 | Burroughs Wellcome Co. | Antiviral compounds |
| DK24089D0 (da) | 1989-01-20 | 1989-01-20 | Hans Bundgaard | Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups |
| US5001115A (en) | 1989-05-17 | 1991-03-19 | University Of Florida | Prodrugs of biologically active hydroxyaromatic compounds |
| FI83421C (fi) | 1989-06-21 | 1991-07-10 | Huhtamaeki Oy | Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat. |
| US5411947A (en) | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
| US5227506A (en) | 1989-09-06 | 1993-07-13 | Merck & Co., Inc. | Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors |
| JPH05501404A (ja) * | 1989-11-06 | 1993-03-18 | ニユコメド・アクシエセルカペト | ヌクレオシド誘導体 |
| ES2083580T3 (es) | 1990-06-13 | 1996-04-16 | Arnold Glazier | Profarmacos de fosforo. |
| US5177064A (en) | 1990-07-13 | 1993-01-05 | University Of Florida | Targeted drug delivery via phosphonate derivatives |
| CA2444071C (en) | 1991-02-08 | 2008-10-07 | Wellstat Therapeutics Corporation | Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| JP3132167B2 (ja) | 1991-08-23 | 2001-02-05 | 藤沢薬品工業株式会社 | デプシペプチド誘導体の製造法 |
| EP0541037A3 (en) | 1991-11-06 | 1997-02-26 | Takeda Chemical Industries Ltd | Squalene synthetase inhibitory composition and use thereof |
| EP0603401B1 (en) | 1992-07-10 | 2001-04-11 | Toray Industries, Inc. | Methanediphosphonate derivative, production thereof, and pharmaceutical use thereof |
| US5484911A (en) | 1993-04-01 | 1996-01-16 | Health Research, Inc. | Nucleoside 5'-diphosphate conjugates of ether lipids |
| GB9515279D0 (en) | 1995-07-25 | 1995-09-20 | Norsk Hydro As | Improved therapeutic agents |
| DE4311801A1 (de) | 1993-04-09 | 1994-10-13 | Hoechst Ag | Neue Carbonsäureester von 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren Herstellung sowie deren Verwendung |
| DE4321946A1 (de) | 1993-07-01 | 1995-01-12 | Hoechst Ag | Methylphosphonsäureester, Verfahren zu deren Herstellung und deren Verwendung |
| WO1995012604A1 (en) | 1993-11-05 | 1995-05-11 | Aktiebolaget Astra | Novel amino acid derivatives |
| IL111584A0 (en) | 1993-11-18 | 1995-01-24 | Merck & Co Inc | Prodrugs of an inhibitor of hiv protease and pharmaceutical compositions containing them |
| DE4342907A1 (de) | 1993-12-16 | 1995-06-22 | Bayer Ag | Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten |
| DE4418690A1 (de) | 1994-05-28 | 1996-01-11 | Boehringer Mannheim Gmbh | Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel |
| US5441942A (en) * | 1994-05-27 | 1995-08-15 | The Scripps Research Institute | 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect |
| US5466811A (en) | 1994-07-18 | 1995-11-14 | Merck & Co., Inc. | Dioxolenylmethyl carbamates pro moieties for amine drugs |
| PE32296A1 (es) | 1994-07-28 | 1996-08-07 | Hoffmann La Roche | Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables |
| US5543414A (en) | 1994-07-28 | 1996-08-06 | Syntex (Usa) Inc. | Achiral amino acid acyl esters of ganciclovir and its derivatives |
| US5696277A (en) | 1994-11-15 | 1997-12-09 | Karl Y. Hostetler | Antiviral prodrugs |
| WO1996021440A1 (en) | 1995-01-09 | 1996-07-18 | Alpha-Therapeutics, Inc. | Methods for increasing the bioavailability of biological active agents |
| US5952499A (en) | 1995-01-16 | 1999-09-14 | Commonwealth Scientific And Industrial Research Organisation | Therapeutic compound-fatty acid conjugates |
| IL113246A (en) | 1995-04-04 | 2004-08-31 | Yissum Res Dev Co | Bisphosphonates and pharmaceutical compositions containing them |
| WO1996033201A1 (en) | 1995-04-21 | 1996-10-24 | Centre National De La Recherche Scientifique (Cnrs) | Acyclovir derivatives as antiviral agents |
| DE19529604A1 (de) | 1995-08-11 | 1997-02-13 | Bayer Ag | Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung |
| US5717095A (en) | 1995-12-29 | 1998-02-10 | Gilead Sciences, Inc. | Nucleotide analogs |
| AU1592897A (en) | 1996-01-26 | 1997-08-20 | F. Hoffmann-La Roche Ag | Process for preparing purine derivatives |
| US5869493A (en) | 1996-02-16 | 1999-02-09 | Medivir Ab | Acyclic nucleoside derivatives |
| JP2001503767A (ja) | 1996-11-12 | 2001-03-21 | メディヴィル・アクチボラグ | ヌクレオシド |
| ATE297904T1 (de) | 1997-04-15 | 2005-07-15 | Genentech Inc | Halo-alkoxycarbonylverbindungen |
| ATE222914T1 (de) | 1997-05-15 | 2002-09-15 | Drug Innovation & Design Inc | Diester-derivate von acyclovir |
| DE69829784T2 (de) * | 1997-08-15 | 2006-02-16 | Medivir Ab | 3'-Fluorierte Guanosinderivate zur Behandlung oder Prophylaxe von HBV- oder retroviralen Infektionen |
| WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
| US6974803B2 (en) * | 2001-12-06 | 2005-12-13 | Pfizer Inc | Pharmaceutical combination |
-
1999
- 1999-02-12 US US09/249,317 patent/US6458772B1/en not_active Expired - Fee Related
- 1999-02-15 EA EA200000838A patent/EA002647B1/ru not_active IP Right Cessation
- 1999-02-15 CA CA002318978A patent/CA2318978A1/en not_active Abandoned
- 1999-02-15 EP EP99932500A patent/EP1054891A1/en not_active Withdrawn
- 1999-02-15 JP JP2000531466A patent/JP2002503673A/ja active Pending
- 1999-02-15 AU AU32820/99A patent/AU754733B2/en not_active Ceased
- 1999-02-15 WO PCT/SE1999/000194 patent/WO1999041275A1/en not_active Ceased
-
2001
- 2001-11-16 US US10/015,184 patent/US6974802B2/en not_active Expired - Fee Related
-
2005
- 2005-08-12 US US11/202,682 patent/US7071173B2/en not_active Expired - Fee Related
-
2006
- 2006-01-18 US US11/335,429 patent/US7825238B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG105230A (en) | Hepatitis c inhibitor peptides | |
| LU91083I2 (fr) | Bortezomib ou un des ester pharmaceutiquement acceptables, optionnellement sous forme d'un sel pharmaceutiquement acceptable-Velcade. | |
| LV12350A (lv) | Heptapeptida oksitocina analogi | |
| LU91306I2 (fr) | Mitratapide, optionnellement sous forme d'un sel d'addition acide pharmaceutiquement acceptable (YARVITAN) | |
| ES2158537T3 (es) | Derivados de acidos ciclopropilalcanoicos. | |
| TR200100432T2 (tr) | Hepatit C inhibitörü tri-peptidler | |
| JP2002541233A5 (cg-RX-API-DMAC10.html) | ||
| IL172403A (en) | D-amino acid peptides | |
| LU91145I2 (fr) | FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX). | |
| WO2002000263A3 (en) | Tripeptide prodrug compounds | |
| JP2005502595A5 (cg-RX-API-DMAC10.html) | ||
| IE801342L (en) | Peptides | |
| PT1021456E (pt) | Derivados macrociclicos de eritromicinas a e b de anel de 13 membros | |
| IS4265A (is) | Afleiður af mycophenolicsýrum, sem hafa efnahópa tengda-N-atómi í stöðu 6 | |
| LU91181I2 (fr) | Ziconotide, optionnellement sous forme d'un sel avec un acide pharmaceutiquement acceptable, y compris acetate de ziconotide (prialt). | |
| NZ594844A (en) | Prion-specific peptoid reagents | |
| DZ3156A1 (fr) | Nouvelle forme polymorphe du sel d'acide 5-Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione, maleique. | |
| DK1018511T3 (da) | Isochromanforbindelser og fremgangsmåde til deres fremstilling | |
| EP1123935A3 (en) | 3'-Fluorinated guanosine derivatives for the treatment or prophylaxis of HBV or retroviral infections | |
| WO2004099240B1 (en) | Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars) | |
| JP2002505336A5 (cg-RX-API-DMAC10.html) | ||
| WO2001072688A3 (fr) | Procede de preparation de la (2s,3r,4s)-4-hydroxyisoleucine et de ses analogues | |
| GB0218816D0 (en) | Antitumoral analogs of lamellarins | |
| JPH10338636A5 (cg-RX-API-DMAC10.html) | ||
| EP1182208A3 (en) | Composition for DNA transfection |